Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Insulin Formulations: Types and Delivery01:27

Insulin Formulations: Types and Delivery

Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into rapid-acting...
One-Compartment Model: IV Infusion01:09

One-Compartment Model: IV Infusion

Intravenous (IV) infusion is often utilized when continuous and controlled drug delivery is necessary, such as during surgery or in the treatment of chronic diseases. This method offers numerous advantages, including immediate drug action, precise control over dosage, and bypassing the first-pass metabolism.
The one-compartment model for IV infusion uses mathematical equations to describe the rate of change in drug quantity in the body. At steady-state or infusion equilibrium, the drug input...
Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices01:28

Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices

Parenteral drug delivery systems play a crucial role in modern therapeutics by enabling the direct administration of drugs into the systemic circulation, bypassing the gastrointestinal tract. These systems are particularly valuable for poorly absorbed oral medications that are unstable in the digestive environment or require rapid onset or sustained therapeutic levels. Delivery is achieved through intravenous, intramuscular, or subcutaneous routes, each selected based on the drug's properties...
IV Infusion to Oral Dosing: Conversion Methods01:28

IV Infusion to Oral Dosing: Conversion Methods

The development of extended-release formulations has facilitated the transition from intravenous to oral medication, offering a more convenient and patient-friendly approach to drug administration. This transition, however, requires careful management to ensure that therapeutic drug levels are maintained, preserving efficacy and avoiding adverse effects. Understanding pharmacokinetic principles and dosage calculations is critical during this process.Pharmacokinetics of the...
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
One-Compartment Open Model for IV Bolus Administration: General Considerations01:19

One-Compartment Open Model for IV Bolus Administration: General Considerations

The one-compartment model is a pharmacokinetic tool that models the body as a single, uniform compartment, facilitating the understanding of drug distribution and elimination. This model is particularly beneficial for intravenous (IV) bolus administration, where the drug rapidly circulates throughout the body.
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant, half-life,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Euglycemic diabetic ketoacidosis in the era of SGLT-2 inhibitors.

BMJ open diabetes research & care·2023
Same author

Algorithm Maxima for Intravenous Insulin Infusion.

Diabetes technology & therapeutics·2020
Same author

Clinical assessment for high-risk patients with non-alcoholic fatty liver disease in primary care and diabetology practices.

Alimentary pharmacology & therapeutics·2020
Same author

Medical Management of the Diabetic Patient.

Clinics in podiatric medicine and surgery·2019
Same author

Treatment of Diabetes in Older Adults: An Endocrine Society* Clinical Practice Guideline.

The Journal of clinical endocrinology and metabolism·2019
Same author

Fungal thyroiditis in a lung transplant recipient.

BMJ case reports·2018

Related Experiment Video

Updated: Jul 2, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Algorithms for intravenous insulin delivery.

Susan S Braithwaite1, Stephen Clement

  • 1University of North Carolina, Division of Endocrinology, Chapel Hill, NC 27599-7172, USA. sbraithw@med.unc.edu

Current Diabetes Reviews
|August 12, 2008
PubMed
Summary
This summary is machine-generated.

This review classifies intravenous insulin infusion algorithms into "IR" and "MR" types based on design. These algorithms use current blood glucose and insulin rates to determine the next insulin infusion rate, aiming for better glycemic control.

More Related Videos

Scalable Fluidic Injector Arrays for Viral Targeting of Intact 3-D Brain Circuits
13:36

Scalable Fluidic Injector Arrays for Viral Targeting of Intact 3-D Brain Circuits

Published on: January 21, 2010

Intravenous and Intra-amniotic In Utero Transplantation in the Murine Model
06:43

Intravenous and Intra-amniotic In Utero Transplantation in the Murine Model

Published on: October 9, 2018

Related Experiment Videos

Last Updated: Jul 2, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Scalable Fluidic Injector Arrays for Viral Targeting of Intact 3-D Brain Circuits
13:36

Scalable Fluidic Injector Arrays for Viral Targeting of Intact 3-D Brain Circuits

Published on: January 21, 2010

Intravenous and Intra-amniotic In Utero Transplantation in the Murine Model
06:43

Intravenous and Intra-amniotic In Utero Transplantation in the Murine Model

Published on: October 9, 2018

Area of Science:

  • Biomedical Engineering
  • Algorithm Design
  • Diabetes Management

Background:

  • Intravenous insulin infusion is crucial for glycemic control in various clinical settings.
  • Existing algorithms for insulin delivery vary in design and input parameters.
  • Optimizing insulin infusion algorithms can improve patient outcomes and reduce complications.

Purpose of the Study:

  • To classify intravenous insulin infusion algorithms based on their design principles.
  • To differentiate between 'IR' (Insulin Rate) and 'MR' (Maintenance Rate) algorithm types.
  • To highlight key features influencing algorithm performance in glycemic management.

Main Methods:

  • Review and classification of existing insulin infusion algorithms.
  • Identification of essential input data: current and previous blood glucose, test times, and previous insulin rate.
  • Definition of output data: next insulin infusion rate and next test time.

Main Results:

  • Two primary algorithm types identified: IR and MR, both aiming for a glycemic target.
  • IR algorithms adjust the next insulin rate incrementally based on current data.
  • MR algorithms use maintenance rate to select an appropriate insulin-glucose function for precise adjustments.

Conclusions:

  • Algorithm design features significantly impact freedom from hypoglycemia and glycemic variability.
  • Future work should address nursing burden, time lags, and narrow euglycemic ranges.
  • Refined algorithms promise negligible hypoglycemia and variability, enabling optimal glycemic management.